Aripiprazole Lauroxil
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Cost-effectiveness analysis of treatment strategies initiating with second-generation antipsychotic long-acting injectables in patients with schizophrenia in the United States.
Journal: Journal of managed care & specialty pharmacy
Published: April 27, 2026
Case Series: Simultaneous Use of Long-Acting Injectable Antipsychotics and Vivitrol or Long-Acting Buprenorphine in Dual Diagnosis Patients with Bipolar Disorder and Substance Use Disorders.
Journal: Psychopharmacology bulletin
Published: March 13, 2026
Beyond medication choice: Predictors of psychiatric readmission after inpatient initiation of long-acting injectable antipsychotics.
Journal: Journal of psychiatric research
Published: February 21, 2026
Serum Aripiprazole Concentrations After Inadvertent Intradeltoid Administration of Aripiprazole Lauroxil 1064 mg: A Case Report.
Journal: Therapeutic drug monitoring
Published: January 28, 2026
Impact of macrophages on the dissolution of LAI suspension prodrugs.
Journal: International journal of pharmaceutics
Published: January 11, 2026
Perimenopause as an obesogenic sensitive period: Contributions to elevated cardiovascular risk.
Journal: American journal of preventive cardiology
Published: November 22, 2025
Mechanistic Modeling of Intramuscular Administration of a Long-acting Injectable Accounting for Tissue Response At the Depot Site.
Journal: The AAPS journal
Published: July 28, 2025
Aripiprazole Lauroxil Every 2 Months for the Treatment of Adults With Schizophrenia: A Post Hoc Analysis of Efficacy by Baseline Severity of Illness From Phase 3b Clinical Trial Data.
Journal: Schizophrenia bulletin open
Published: June 09, 2025
Treatment Patterns and Outcomes from OASIS: A Prospective Observational Study of Long-Acting Injectables in Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: April 22, 2025
Treatment Patterns and Healthcare Resource Utilization Following Initiation of Aripiprazole Lauroxil Using a 1-Day Initiation Regimen in Patients with Schizophrenia.
Journal: Advances in therapy
Published: February 27, 2025
Aripiprazole Lauroxil Every 2 Months or Paliperidone Palmitate Monthly for Acute Schizophrenia: A Post Hoc Analysis of PANSS Five-Factor Scores in the ALPINE Trial.
Journal: Neuropsychiatric disease and treatment
Published: December 05, 2024
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: October 16, 2024
Last Updated: 06/30/2026